Danh mục

Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: A randomized controlled trial

Số trang: 13      Loại file: pdf      Dung lượng: 3.34 MB      Lượt xem: 5      Lượt tải: 0    
Jamona

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Neoadjuvant chemotherapy (NACT) is the prime approach to the management of locally advanced breast cancer (LABC). Influenced by different factors such as pathologic tumor characteristics, hormone receptor status, HER2 and proliferation marker expressions, response to therapy cannot be easily predicted.
Nội dung trích xuất từ tài liệu:
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: A randomized controlled trial

Tài liệu được xem nhiều:

Gợi ý tài liệu liên quan: